When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk

When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A₂ and C-reactive protein for stroke risk

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

101 Scopus citations

Original language	English (US)
Pages (from-to)	2454-2456
Number of pages	3
Journal	Archives of Internal Medicine
Volume	165
Issue number	21
DOIs	https://doi.org/10.1001/archinte.165.21.2454
State	Published - Nov 28 2005

@article{a19cdcdb1bb8456baa7157a3b4e646bd,

title = "When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk",

author = "Philip Greenland",

year = "2005",

month = nov,

day = "28",

doi = "10.1001/archinte.165.21.2454",

language = "English (US)",

volume = "165",

pages = "2454--2456",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "21",

}

TY - JOUR

T1 - When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk

AU - Greenland, Philip

PY - 2005/11/28

Y1 - 2005/11/28

UR - http://www.scopus.com/inward/record.url?scp=28344442460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344442460&partnerID=8YFLogxK

U2 - 10.1001/archinte.165.21.2454

DO - 10.1001/archinte.165.21.2454

M3 - Editorial

C2 - 16314539

AN - SCOPUS:28344442460

VL - 165

SP - 2454

EP - 2456

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 21

ER -